A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

Inclusion Criteria: * Total testosterone level \<10.4 nanomoles per liter (nmol/L) \[300 nanograms per deciliter (ng/dL)\] at screening * Presents with 1 or more of the following symptom(s) of ejaculatory dysfunction: delayed ejaculation, anejaculation, decreased force of ejaculation, or decreased ejaculatory volume, as determined by investigator assessment * Prostate-Specific Antigen (PSA) \<4 nanograms per milliliter (ng/mL) at screening Exclusion Criteria: * Sexual partner who is or becomes pregnant at any time during the study * Premature ejaculation as determined by investigator assessment * Currently receiving testosterone replacement therapy or have a history of insufficient response to testosterone replacement therapy for ejaculatory dysfunction symptoms * Currently receiving treatment with cancer chemotherapy or antiandrogens * History of use of estrogenizing agents * Current use of warfarin * History of selective serotonin reuptake inhibitor (SSRI) and/or serotonin-norepinephrine reuptake inhibitor (SNRI) treatment in the 6 months prior to screening * History of frequent opioid use within 30 days prior to screening, with exception of treatment for chronic pain as determined by investigator. * Body Mass Index (BMI) \>35 kilograms per square meter (kg/m\^2) at screening * Significant peripheral neuropathy affecting erectile, ejaculatory, or orgasmic function * Hematocrit ≥50% at screening * Exhibit systolic blood pressure \>170 millimeters of mercury (mm Hg) or \<9…